| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 32 |
| 1 | FLUOXETINE HYDROCHLORIDE | 27 |
| 2 | RITONAVIR | 26 |
| 3 | ATAZANAVIR | 25 |
| 4 | OLANZAPINE | 25 |
| 5 | VENLAFAXINE HYDROCHLORIDE | 22 |
| 6 | FOLIC ACID | 20 |
| 7 | LEVETIRACETAM | 19 |
| 8 | FLUOXETINE | 18 |
| 9 | LAMOTRIGINE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 1 | ACETAZOLAMIDE SODIUM | 12 | 0.0020 |
| 2 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 3 | ATAZANAVIR | 25 | 0.0017 |
| 4 | TAZAROTENE | 2 | 0.0017 |
| 5 | DORZOLAMIDE | 13 | 0.0016 |
| 6 | PENICILLAMINE | 1 | 0.0011 |
| 7 | LAMIVUDINE AND ZIDOVUDINE | 8 | 0.0010 |
| 8 | RITONAVIR 100 MG | 13 | 0.0009 |
| 9 | ZIDOVUDINE | 9 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 41 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 33 |
| 2 | Protease Inhibitor [EPC] | 33 |
| 3 | Mood Stabilizer [EPC] | 32 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 6 | Benzodiazepine [EPC] | 21 |
| 7 | Anti-epileptic Agent [EPC] | 20 |
| 8 | Vitamin B12 [EPC] | 20 |
| 9 | Vitamin C [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Protease Inhibitor [EPC] | 33 | 0.0007 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 12 | 0.0006 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 33 | 0.0005 |
| 4 | Progesterone [EPC] | 12 | 0.0005 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 7 | Nitrofuran Antibacterial [EPC] | 4 | 0.0002 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 9 | Mood Stabilizer [EPC] | 32 | 0.0001 |